knowledge -WSS

knowledge

author：Wikipedia 2025-10-04 04:01:58 - browse：97

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

WSS

Biden administration begins canceling student loan debt for 804,000 borrowers

Mark Cuban is blaming the wrong people for high drug costs

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Indictment alleges Trump's ex

Altering the blood type of lungs raises potential for universal organs for transplants

Millions may soon lose Medicaid when they don't have to

focus

knowledge

entertainment

Apple is now the first public company to be valued at $3 trillion

Mark Cuban is blaming the wrong people for high drug costs

United colonoscopy coverage change 'may cost lives,' doctors say

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

George Santos makes 1st court appearance after pleading not guilty to 13 counts

YouTube cracks down on misinformation on cancer treatment

What does generative AI mean for health care? We asked experts

The thinking behind the controversial eating disorder chatbot Tessa

Alkermes shareholders re

Inside the rise of 'mukbang' eating videos

entertainment

Illinois Supreme Court finds assault weapons ban constitutional

Hospitals are dialing back on venture capital investing

A public health expert passes on football's full body collisions for youths

Surge in Apellis stock fueled by confidence in safety of its eye drug

Eli Lilly’s Mounjaro succeeds in second weight

How to fix the rural physician shortage in the U.S.

knowledge

entertainment

entertainment

focus